Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Volume 1793, Issue 1, Pages 212-218Publisher
ELSEVIER
DOI: 10.1016/j.bbamcr.2008.07.024
Keywords
Cardiolipin; Barth syndrome; Protein import; Aging; Mitochondrial bioenergetics and biogenesi; Cell wall
Categories
Funding
- National Institutes of Health [HL 62263, HL084218]
- Barth Syndrome Foundation
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062263, R21HL084218] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Cardiolipin (CL), the signature lipid of mitochondria, plays a critical role in mitochondrial function and biogenesis. The availability of yeast mutants blocked in CL synthesis has facilitated studies of the biological role of this lipid. Perturbation of CL synthesis leads to growth defects not only during respiratory growth but also under conditions in which respiration is not essential. CL was shown to play a role in mitochondrial protein import, cell wall biogenesis, aging and apoptosis, ceramide synthesis, and translation of electron transport chain components. The genetic disorder Barth syndrome (BTHS) is caused by mutations in the tafazzin gene resulting in decreased total CL levels, accumulation of monolysocardiolipin (MLCL), and decreased unsaturated fatty acyl species of CL The variation in clinical presentation of BTHS indicates that other physiological factors play a significant role in modifying the phenotype resulting from tafazzin deficiency. Elucidating the functions of CL is expected to shed light on the role of this important lipid in BTHS and other disorders of mitochondrial dysfunction. (C) 2008 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available